| Tag | Content |
|---|
EnhancerAtlas ID | HS019-00252 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr1:23824230-23826260 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxa2 | MA0047.2 | chr1:23826218-23826230 | GCAAAGTAAACA | - | 6.27 | | Foxd3 | MA0041.1 | chr1:23824631-23824643 | GTTTGTTTGTTT | + | 6.32 | | RUNX1 | MA0002.2 | chr1:23824639-23824650 | GTTTGTGGTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09947 | chr1:23823334-23824993 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I023497 | chr1 | 23823661 | 23824294 |
|
Enhancer Sequence | CTTCTTTCCT TAGGCAAGCA TCTCCTTCAG GCCCCATCCC CAACCCTCTC TGAGTCCATC 60
TTTCCATAGA TGAGCCCATC CGAGCTCCCA GAGCATTCTA TTCTTCCTTG ATGGTGGCAT 120
TTATAACACT TTATTAAACG ACATATTTAT AAGACATGAA GTTTGGCTAG AGGTTAAGAG 180
TAGGGTTTCC TGGGGCTGCA TGGCCTGGGC TCTATCACAT GTTGTGTGAC TTTGTACACA 240
TTGCCCAACC TCTCTGAGTC TCAATTTCCT CATTTGTAAA CATGGGGCTA ATAACAATAC 300
CTACTTTATA GGGTTTTGCC AGAAACCATT TAGCCATAAC TTTTAATGGC AAAAACCGCA 360
ATTACTTTTG CACCAACCTA ATAAATGATT TTGTTGTTGT TGTTTGTTTG TTTGTGGTTT 420
TTTTTTTTTG GTTGTTTGAG ATGGGGTCTC ACTCTGTTGC CCAGGCTGGA GTACAGTGGC 480
ATGCTTATGA CTCACTGCAC CCTAGACCTT CTGGGCTCAG GTGATCCTTC CAGCTCAGCC 540
TCTCAAAGGG CTGGGACTAC AGGCCACCAC CATGCCTGGC TAATTTTTTG TATTTTTTGT 600
AGAGATGGGG TTTCACTATG TTGTCCAGGC TGGTCTCAAA CACATGGGCT TAAGTGATCC 660
ATCTGCCTCC CAAAGTGCTG GGATTACAGG TGTGAGCTAC CACGCTTGGC CGGAAGCTAA 720
ATGATGTTAT GCACACGAGG CCCTAATTTG TTGAATAAAT GAATGAGCAA GTGAGTGAAT 780
CCACTGGGCT GTGAGCTCCT CAAGAATAAG GATTGTTTTC TTTCTTTTTT ACATTTTGCA 840
ATGTCTGAAT CCCAGTGTGG GCATTGCATG TTATCTGGTG CGGTGGTCCT CCTGACCAGT 900
ATTCTCAACA TCACCTTGGA GCTTGTTAGA GATGCCCTTT TTTTTTTTTT TTTTTTTTTT 960
TTTTTTTTTT CAGATGGAGT TTCACTCTTG TTGCCCAGGC TGGAGTGCAA TGACACAATC 1020
TCAGCTCACC GCAACCGCCG CCTCCCAGGT TCAAGCAATT CTCTGGCCTC AGCCTCTCAA 1080
GTAGCTGGGA TTACAGGCAT ACGCCACCAC ACCCGGCTAA TTTTGTATTT TTAGTAGAGA 1140
CAGGGTTTCT CCATGTTGGT CAGACTGGTC TCGAACTCCC CACTTCAGGT GAGCTGCCTG 1200
CCTTGGCCTC CCAAAGTGCT GGGATTACAG GCATGAGCCA CCACGCCCAG CCCAGAAATG 1260
TCCATTTTTA GGTCCCACCT GTGACCTACT GAATCAGAAA TTCTAGGGAT GGAGCCCAGC 1320
AAGCTGTACT CTAACAAGCC CTCTGATTCT GATGAGCGCT AAAGTTTGGG ATCTACCCAG 1380
CCAGCACATA GAGGCTCAAA GGTGTTTGTC TAAATATATG TTCAAATCCA TAAGCTTTAT 1440
GTGGTTTGAA TTAGAATTGG CTGTAAGCTC CATAAAATGA GGGGGCATGG TTTCCCTAGC 1500
ACCAGGTAGA GGCAGGCGCA TAGTAGATGC TCAAAAAAGG TTTGTGGGCC GGGCTCAGTG 1560
GCTCATGCCT GTAATCCCTC CTGCTTGGGA GGCAGAGGCA AGCAGATCAC TTGAGGTCAG 1620
GAGTTTGAGA CCAACCTGTC CAACATGGCA AAACCCCACC TCTACTAAAA ATACAAAAAT 1680
TAGCCGGGTG TGGTGGTGGG CGCCTGTAGT CCCAGCTACT CAGGAGGCTG AGGCACGAGA 1740
ATTTCTTGAA CCCTGGAGGT GGAGGTTGCA GTGAGCCAAG ATCGTGCCAC TGCACTCTAG 1800
CCTGAGCAAC ATAGCAAGAC TCTGTCTCAA AAAAAAAAAA AAAAAAAAAA GGAAAAGTTT 1860
TGTGAAACAA ATGAACAAAT GAGTGAAGAG CCCTTTTGGT TCTTTTTATG GTTCTCAGTA 1920
TCTTAGATTT TCCAAAGTTC AGTTTCATTA CCTGTTCTCT CTTCCAGGAT CTGTGGAAGG 1980
ATCTACAAGC AAAGTAAACA GCTTAATATA CAAAACAAAA AAGTATTGTC 2030
|
